Erin Blonshine, a 29 year old teacher from Dacula, Georgia, was diagnosed at 21 with AML, a form of Leukemia. Across the globe, Johannes Saur from Ulm, in southern Germany had joined his country’s bone marrow registry at the age of 18, and at 20, when Erin was diagnosed, Johannes got a call that he was a match for an American. At that time, Erin’s cancer went into remission before the transplant was needed, but a year later, it resurfaced. “Her leukemia relapsed, and we knew that the only potential cure was a transplant,” says Amelia Langston, MD, Medical Director of Winship’s Bone Marrow & Stem Cell Transplant Center. In August of 2009, Johanne’s bone marrow was flown to the U.S. for Erin’s transplant, and today, she has made a complete recovery. “5 years, for most leukemia survivors, means cure. It means we’re done worrying about the leukemia,” says Langston. If Erin ever wondered if her perfect match was out there, now she knows. To learn more about Winship’s Bone Marrow Transplant Center and Erin’s journey to recovery after her transplant, check out the video story from Fox 5 News below:
One out of every two men in the United States will be diagnosed with cancer at some point in our lives. It’s a sobering statistic to consider as we head into Father’s Day weekend. Beyond skin cancer, men are most frequently diagnosed with prostate, lung or colorectal cancer. Those are also the three malignancies responsible for the highest number of deaths in men.
Reducing your risk of cancer is more important than ever. Here are four ways to make an impact today.
- If you use any tobacco products, quit now. Cigarette smoking is responsible for more than a dozen types of cancer including those involving our lungs, bladder, and mouth. Chewing tobacco and snuff can also cause head and neck, esophageal, stomach or pancreatic cancer. Talk with your doctor about the best ways to help you kick the habit for good. Finding a support group can also make a big difference in whether you succeed.
- Cut back on alcohol consumption. Heavy drinking can cause health problems, but did you also know that alcohol can increase your risk for cancers of the mouth, throat, liver and colon? Even worse: drinking and smoking at the same time. It is recommended that men consume no more than two alcoholic drinks a day. In case you were wondering, one drink contains 12 ounces of beer, 5 ounces of wine or 1.5 ounces of 80-proof liquor.
- Listen to your wife or partner and get a checkup. Starting at the age of 50, men at average risk for colorectal cancer should have a colonoscopy. If no polyps are found, the test should be repeated every 10 years. Your doctor may recommend a fecal occult blood test at an earlier age. Also at 50, talk with your doctor about the pros and cons of getting a PSA test to screen for prostate cancer. If you are considered to be in a high-risk group, your doctor may recommend that you be tested earlier.
- Get off the couch and get some exercise. You’ve heard it before, but as a doctor, I can tell you that regular physical activity is one of the best ways to control your weight, reduce stress and lower your risk of cancer. Try to get at least 150 minutes of moderate intensity exercise each week or 75 minutes of vigorous workouts.
As you get ready to celebrate Father’s Day, put down that cigarette and beer, get outside and grab a tennis racket, a soccer ball or even a Frisbee. Also don’t forget to wear sunscreen…at least with a SPF of 30! Have a great Father’s Day!!!
About Dr. Curran
Walter J. Curran, Jr., MD was appointed Executive Director of Winship Cancer Institute of Emory University in 2009. He joined Emory in January 2008, as the Lawrence W. Davis Professor and Chairman of Emory’s Department of Radiation Oncology. He also serves as Group Chairman and Principal Investigator of the Radiation Therapy Oncology Group (RTOG), a National Cancer Institute-funded cooperative group, a position he has held since 1997. Curran has been named a Georgia Research Alliance Eminent Scholar and Chair in Cancer Research as well as a Georgia Cancer Coalition Distinguished Cancer Scholar.
Dr. Curran has been a principal investigator on over thirty National Cancer Institute-supported grants and is considered an international expert in the management of patients with locally advanced lung cancer and malignant brain tumors. He has led several landmark clinical and translational trials in both areas and is responsible for defining a universally adopted staging system for patients with malignant glioma and for leading the randomized trial which defined the best therapeutic approach to patients with locally advanced lung cancer. He serves as the Founding Secretary/Treasurer of the Coalition of Cancer Cooperative Groups and is a Board Member of the Georgia Center for Oncology Research and Education (Georgia CORE). Dr. Curran is the only radiation oncologist to have ever served as Director of a National Cancer Institute-Designated Cancer Center.
Dr. Curran is a Fellow in the American College of Radiology and has been awarded honorary memberships in the European Society of Therapeutic Radiology and Oncology and the Canadian Association of Radiation Oncology. According to the Blue Ridge Institute for Medical Research, Dr. Curran ranked among the top ten principal investigators in terms of National Cancer Institute grant awards in 2013, and was first among investigators in Georgia, and first among cancer center directors.
Have you ever wondered about the biology behind cancer? If so, join Assistant Professor of Hematology and Medical Oncology, Gregg Orloff, Ph.D, on Tuesday, August 6 at noon for an interactive, live, web chat on the “Biology of Cancer.” He will be available to discuss questions such as:
- What is cancer?
- What causes cancer?
- What can you do to prevent cancer?
- How is cancer diagnosed and treated?
- What is the role of infectious organisms like viruses in cancer?
- Why and how cancer spreads.
- Why do cancer drugs not always work.
This interesting chat will open your eyes to what cancer is and what you can do to help reduce the chances that you or your family members will be diagnosed with the disease.
‘Tis the season for indulgence, fa la la la la la la la laaaaa! With the holiday season upon us, it’s hard to resist the urge to overindulge. While it is important for everyone to know how to make healthy choices when it comes to nutrition and exercise, incorporating the right foods a nutritional elements into one’s diet is especially important for cancer survivors. According to the National Cancer Institute, an individual is considered a cancer survivor from the time of diagnosis through the balance of his or her life. Understanding the role nutrition plays before, during, and after cancer treatment is critical to ensuring cancer survivors are as strong as possible through their journey in the fight against cancer.
Because nutritional recommendations can be very different for cancer patients than for the average healthy adult, Tiffany Barrett, MS, RD, CSO, LD, of the Winship Cancer Institute of Emory University, is hosting an online chat on Tuesday, December 11, 2012 at noon EST to share her insights on optimal nutrition to support the journey in the fight against cancer.
Be proactive this holiday season and join Tiffany and our other chat participants to share tips, ideas, and get questions answered related to the best nutritional choices you can make this holiday season and beyond!
We held a chat on the topic of breast cancer with Dr. Toncred Styblo in October. From that chat, we got lots of great questions and feedback and even a couple questions we couldn’t get to in the chat’s allotted time. Dr. Styblo has taken the time to answer those questions for this follow up blog post, mostly covering questions related to ductal carcinoma in situ (DCIS), a type of breast cancer typically found in the lining of the milk ducts that has not yet invaded nearby tissues.
Below are the questions Dr. Styblo has covered in this post:
- How long does one continue to follow up with oncologist and surgeon after DCIS diagnosis and resultant mastectomy?
- What is the risk of recurrence in other breast after DCIS and mastectomy?
- Does that include blood work for Ca27-29, and how often?
- I’m interested in risk of recurrence after DCIS diagnosis. If you continue to follow your patients for life (which Dr. Styblo mentioned in the chat that she does), that suggests a moderate risk for recurrence.]
- What would you suggest in the case of multifocal DCIS?
Answers from Dr. Styblo:
DCIS, intraductal cancer and in situ ductal cancer are names for stage “0″ breast cancer. Stage 0 breast cancer is cured by removing it completely with surgery, but does not have any affect on the risk of developing a second breast cancer in that breast or the other breast.
The surgery to remove the cancer may be a lumpectomy or it might be a mastectomy. This risk of a patient developing another breast cancer post-surgery is dependent on many factors and the risk is best assessed by your doctor. The subsequent follow up and recommendations about screening and risk reduction will be dependent on additional factors including the pathologic features of the DCIS and the patient’s risk of developing a second breast cancer.
Because DCIS is stage 0 breast cancer, follow up is primarily to screen for another breast cancer rather than recurrence. The screening includes breast imaging and clinical exam, there are no blood tests indicated.
Dr. Styblo also received a question on the topic of support in the chat: What role, in your opinion does emotional support play in achieving the best possible outcome after breast cancer? Where or how do you recommend patients find advocates? The Winship Cancer Institute has several programs for survivors and support, including the Peer Partner Program which “matches cancer survivors and caregivers with cancer patients and caregivers dealing with a similar diagnosis of cancer, pre-cancerous condition, or benign tumor.”
Breast Health & Breast Cancer Related Resources:
- Quiz – Breast Cancer High Risk Quiz
- Web Site – Winship at Emory Breast Cancer Resources
- Web Site – Emory Breast Health Center
- Blog Post – Nutrition for Cancer Patients
Most women are familiar with the Pap smear, also known as the pap test. Most of us are also aware that the main goal of the Pap smear is to identify cancerous or abnormal cells that may turn into cancer after collecting them from the lining of the cervix. However, based on findings recently published in the International Journal of Cancer, Pap smears may not be the most reliable way to pinpoint cancer types that can often be harder to detect.
According to Kevin Ault, MD, an associate professor of obstetrics and gynecology at Emory’s School of Medicine and Winship Cancer Institute, the Pap smear is not always effective in the diagnosis of adenocarcinoma. Ault came to this conclusion after conducting a post-hoc analysis of Gardasil vaccine trials. Adenocarcinoma is a type of cervical cancer that begins significantly far up the cervical canal, an area that often is not sampled when a Pap smear is conducted.
Andenocarcinoma is the second most common type of cervical cancer, accounting for about 20 percent of all cervical cancer cases. While the overall incidence rate of cervical cancer is on the decline, Ault reports the proportion of andenocarcinoma cervical cancer is rising.
As the 8th most common type of cancer in American women, more than 12,000 new cases of invasive cervical cancer are diagnosed each year. Scientists believe that pre-invasive cervical cancer may develop over a period of months or years after the cervix is infected with the sexually transmitted HPV.
A leading expert and pioneer in the field of human papilloma virus (HPV), Ault suggests women might seek an HPV and Pap test at the same time. Why? A positive HPV test may be an indicator for early stages of adenocarcinoma cervical cancer that can’t be determined via a standard Pap test.
If you’ve been following our cancer blog, you’ve probably seen some of our efforts to keep breast cancer awareness going not just in October, which is Breast Cancer Awareness Month, but year round. The Winship Cancer Insitute of Emory University just received a truly generous gift that will make that fight, and the fight against breast cancer on the whole, a whole lot easier.
The Wilbur and Hilda Glenn Family Foundation has generously committed $5 million to the Winship Cancer Institute. The commitment will name the Glenn Family Breast Program at Winship, establishing a fund to support patient care, research, education and community outreach.
More than 200,000 women in the U.S. will be newly diagnosed with breast cancer this year, and one in eight women will be diagnosed with breast cancer in her lifetime. The gift bestowed upon Winship from the Glenn Foundation will allow the cancer treatment team at the Winship Cancer Institute to further advance results in the research and treatment of breast cancer.
Some of the initiatives in place to achieve this expansion of breast cancer research and treatment include:
- A Strengthened Effort in Breast Cancer Biobanking: expand and strengthen breast cancer tumor banking efforts at the Winship Cancer Institute and leverage collaborations with the Avon Comprehensive Breast Center at Grady and Emory University Midtown Hospital. This will make Winship’s breast cancer tissue bank among the most robust in the nation and will ensure full integration of patient outcomes.
- High Risk Breast Cancer Care: Building on its strength in assessing women at high risk for breast cancer or disease recurrence and its history of collaboration with other cancer centers, Winship will expand its multi-disciplinary approach to screen and care for more women.
- Seed Grants: Building on the success of the established Glenn Scholars program, these seed grants will support young investigators in their research in four critical areas: new therapeutics, early detection, health disparities and imaging.
- Clinical Trials: The Glenn Foundation grant will contribute to new clinical trials, including novel treatment trials such as those targeting women with high-risk breast cancer, such as triple negative disease and those women who currently lack access to quality breast health care and treatment.
- Survivorship: The gift will strengthen Winship’s survivorship program to include an online database to match patients and caregivers with trained peer partners who offer support and guidance throughout treatment.
- Community Access: Winship will build a stronger coordinated community outreach program to enhance access to cancer screening and early detection services throughout and beyond metro Atlanta.
We thank the Glenn Foundation for the very generous gift and look forward to seeing lots of great developments in the research and treatment of breast cancer from the Winship Cancer Institute.
Every year, Georgia Tech’s women’s basketball team hosts a PINK game to raise awareness for breast cancer. This year, Tech is teaming up with the Emory Breast Center and Winship Cancer Institute of Emory University to honor breast cancer survivors at the game.
This year’s PINK game is a home game match-up between Georgia Tech (25) and NC State. Tip-off will take place at 5pm on Sunday, February 13, and the game will be broadcast on ESPN2. To keep breast cancer awareness top of mind, Tech’s Ramblin’ Wreck women basketball players will wear pink jerseys for the game and will enter the arena by running through a typical tunnel, made up of not-so-typical participants*. Breast cancer survivors from around Georgia will form the tunnel to welcome the team to their home stadium.
So why should you care? One in 8 women will be diagnosed with breast cancer in her lifetime. That’s why we ask that you join Emory and Georgia Tech as we wage a “full court press” against the disease and raise awareness about the importance of screening mammography and understanding breast cancer risk.
*We are still recruiting breast cancer survivors to form the team’s tunnel! As an honoree, survivors will receive a free ticket to the game and a pink Emory Breast Center t-shirt to wear on game day. It is not a requirement that participating survivors have been treated at Winship at Emory.
Please join us for this special event. You can register by calling 404-778-7777 or visit www.emoryhealthcare.org/pink for more information.
January is Cervical Health Awareness Month – a time to highlight issues related to cervical cancer, HPV disease and the importance of early detection. It’s also a time to celebrate all of the wonderful progress that has been made in the United States over the last four decades to diagnose, prevent and treat the disease. Cervical cancer is now almost 100% preventable and curable if detected early.
Cervical cancer is a slow-growing cancer that forms in tissues of the cervix (the organ connecting the uterus and vagina), generally with no symptoms unless it has progressed to more advanced stages. It was once the leading cause of cancer death for women in the US, but has seen a dramatic decline in incidence and mortality rates because of regular screening programs, the cervical cancer vaccine and improved treatment options.
In the U.S., the cause of the majority of cervical cancers is linked to two particular high-risk types of the human papilloma virus (HPV), types 16 and 18. Since HPV is passed from person to person through sexual contact, most men and women will become infected at some point in their lives and fortunately most infections clear up on their own. But when a woman has a persistence of one of the high-risk HPV types and it causes pre-cancerous changes of the cervix, she may need treatment of these pre-cancer changes and closer follow-up with her doctor.
The single most important thing a woman can do is to have a regular Pap test as part of a routine pelvic exam. Not only does the Pap test identify cancer cells but also abnormal cells that are pre-cancerous and could lead to cervical cancer. Early detection means treatment, such as surgery, radiation therapy or chemotherapy, is more likely to be effective.
Vaccines have been developed in recent years to prevent acquiring the high-risk HPV infection, essentially stopping cervical cancer before even the first step can begin. The vaccines are recommended for girls, ages 11 and 12, allowing the immune system to be activated before a girl is likely to be exposed to HPV.
Researchers have also been developing surgical techniques to cure localized cancers while preserving as much normal tissue as possible. Dr. Peter Rossi and I are currently conducting a study at the Winship Cancer Institute of Emory University, researching how much actual radiation is delivered against cervical tumors. This type of “GPS” for the body is being evaluated in order to deliver radiation more accurately and targeted directly to the cancerous tissue. If successful, the effectiveness of radiation treatment may be improved and more importantly, unwanted side effects may be reduced.
Any woman can get cervical cancer, but it occurs more often in African-American and Hispanic women than in non-Hispanic white women. Those who are most at risk for the disease, though, are women who do not have regular checkups that include Pap tests. So, talk to your doctor today and schedule a Pap test. It could save your life.
Dr. Makhija is Director Gynecologic Oncology and Associate Professor of Gynecology and Obstetrics. Her research interests include chemo-resistance in ovarian cancer and the development of novel, targeted therapeutics including monoclonal antibodies and gene therapies for ovarian cancer. Additional research interests include the extension of cervical cancer clinical trials to under-served women, particularly in India, as well as education and participation in the HIV Prevention Trials Network. She has published numerous peer-reviewed scientific papers and review articles in journals such as International Journal of Oncology, American Journal of Obstetrics and Gynecology, Oncogene, and Women’s Oncology Review.